Transplantation as salvage therapy for high-risk patients with myeloma in relapse.
about
Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplaCure of multiple myeloma -- more hype, less reality.Cytogenetically defined myelodysplasia after melphalan-based autotransplantation for multiple myeloma linked to poor hematopoietic stem-cell mobilization: the Arkansas experience in more than 3,000 patients treated since 1989.Outcomes of salvage autologous versus allogeneic hematopoietic cell transplantation for relapsed multiple myeloma after initial autologous hematopoietic cell transplantation.The Diagnosis and Treatment of Multiple MyelomaConsensus statement from European experts on the diagnosis, management, and treatment of multiple myeloma: from standard therapy to novel approaches.Treatment strategies in relapsed and refractory multiple myeloma: a focus on drug sequencing and 'retreatment' approaches in the era of novel agents.Second autologous transplant as salvage therapy in multiple myeloma.Current strategies for treatment of relapsed/refractory multiple myeloma.Toxicity of a second autologous peripheral blood stem cell transplant in patients with relapsed or recurrent multiple myeloma.When to recommend a second autograft in patients with relapsed myeloma?
P2860
Q35999062-C3510F6A-07E8-4621-9105-846797FFDA94Q36301128-41752222-7465-4C58-97DA-DF8F7D273292Q36384679-BF6451F6-D09D-4B8A-953C-DB0B6DF35619Q36834629-A59D620F-BC3C-413B-A495-6255C930A91AQ37150733-4614C6F0-38F1-4E1F-B89D-6C7D21DE689DQ37761370-55D5BEF2-FAD4-4824-A9F1-DE293DA157D2Q37949201-82B52B1A-2BDC-4E3A-ACCD-F8EB1253E19DQ38151157-628E45FE-DD53-4964-9FA2-A8FA6315A650Q38182683-DDF78C5D-A462-4247-B3B9-7FCA70ACD062Q45918038-CA53B2C0-7EAE-47F6-9D07-11E1AFEF2D4AQ48921667-E2C89560-0FF5-4EA4-AD28-35160437BC2C
P2860
Transplantation as salvage therapy for high-risk patients with myeloma in relapse.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Transplantation as salvage therapy for high-risk patients with myeloma in relapse.
@en
Transplantation as salvage therapy for high-risk patients with myeloma in relapse.
@nl
type
label
Transplantation as salvage therapy for high-risk patients with myeloma in relapse.
@en
Transplantation as salvage therapy for high-risk patients with myeloma in relapse.
@nl
prefLabel
Transplantation as salvage therapy for high-risk patients with myeloma in relapse.
@en
Transplantation as salvage therapy for high-risk patients with myeloma in relapse.
@nl
P2093
P2860
P356
P1476
Transplantation as salvage therapy for high-risk patients with myeloma in relapse.
@en
P2093
Anaissie E
Barlogie B
Cottler-Fox M
Thertulien R
P2860
P2888
P304
P356
10.1038/SJ.BMT.1703715
P407
P577
2002-12-01T00:00:00Z